CD1a affects the recurrence and prognosis of ovarian cancer

被引:0
作者
Zhu, Qiong [1 ]
Liu, Jun [2 ]
Xie, Yinghao [1 ]
Wu, Chengqiu [1 ]
机构
[1] Univ South China, Sch Publ Hlth, Hengyang, Peoples R China
[2] Hengyang Cent Dis Control & Prevent, Hengyang, Peoples R China
关键词
CD1a; ovarian cancer; prognosis; recurrence; recurrent ovarian cancer; DENDRITIC CELL-DENSITY; EXPRESSION; ACTIVATION; PREDICTS; NUMBER;
D O I
10.1111/jog.16120
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Explored the correlation between CD1a expression in recurrence and prognosis of ovarian cancer (OV). Methods: The CD1a expression profile in OV, recurrent OV, and normal tissues, as well as corresponding clinical data, were obtained from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC), Gene Expression Omnibus (GEO), and Genotype Tissue Expression (GTEx) databases. Meanwhile, immunohistochemical detection of CD1a expression in normal and OV tissues. Kaplan-Meier curves were plotted to estimate the hazard ratio (HR) of survival in OV. In addition, the correlation between CD1a and immune cells in OV, as well as the CD1a expression profile and corresponding survival time in pan-cancer were obtained from TCGA database. Results: CD1a was overexpressed in OV and was significantly under-expressed in recurrent OV (TCGA-OV, p < 0.0001 and ICGC-OV, p < 0.0001). CD1a immunohistochemistry is significantly overexpressed in OV compared to normal tissue (p < 0.05). Recurrent OV (ICGC, p < 0.001; GSE17260, p < 0.001; GSE32062, p < 0.05). The prognosis in OV was significantly better when CD1a is overexpressed compared to under-expressed (HR [low], 1.426: 95% confidence interval [CI], 0.912-2.128; p = 0.050). Meanwhile, the overexpression of CD1a has a better prognosis than low expression in OV and recurrent OV (p = 0.004, HR [low] = 2.462, 95%CI [1.346-4.504] and p = 0.011, HR [low] = 2.199, 95%CI [1.202-4.024]). In addition, CD1a expression was closely correlated with immune cells, the CD8+ T cells, macrophages, and NK cells, while uncharacterized cells were significantly different (p = 2.65e-6, p = 7.52e-13, p = 8.28e-12, and p = 5.89e-8, respectively). Moreover, CD1a expression affected the prognosis in various other cancers. Conclusions: CD1a expression affected the recurrence and prognosis of OV and is closely related to various immune cell levels.
引用
收藏
页数:9
相关论文
共 50 条
[31]   hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer [J].
Wittinger, Michael ;
Vanhara, Petr ;
El-Gazzar, Ahmed ;
Savarese-Brenner, Bettina ;
Pils, Dietmar ;
Anees, Mariam ;
Grunt, Thomas W. ;
Sibilia, Maria ;
Holcmann, Martin ;
Horvat, Reinhard ;
Schemper, Michael ;
Zeillinger, Robert ;
Schoefer, Christian ;
Dolznig, Helmut ;
Horak, Peter ;
Krainer, Michael .
CLINICAL CANCER RESEARCH, 2011, 17 (24) :7816-7827
[32]   Comprehensive pathway-related genes signature for prognosis and recurrence of ovarian cancer [J].
Zhao, Xinnan ;
He, Miao .
PEERJ, 2020, 8
[33]   SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer [J].
Vancza, Lorand ;
Horvath, Anna ;
Seungyeon, Lee ;
Rokusz, Andras ;
Dezso, Katalin ;
Reszegi, Andrea ;
Petovari, Gabor ;
Goette, Martin ;
Kovalszky, Ilona ;
Baghy, Kornelia .
CANCERS, 2023, 15 (07)
[34]   Ovarian cancer prognosis and soft computing [J].
Odusanya, AA .
SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW TECHNOLOGIES, 2002, :60-61
[35]   Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer [J].
Liang, Jun ;
Yang, Bo ;
Cao, Qinying ;
Wu, Xiaohua .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2016, 81 (06) :529-536
[36]   Four genes relevant to pathological grade and prognosis in ovarian cancer [J].
Pan, Xue ;
Chen, Ying ;
Gao, Song .
CANCER BIOMARKERS, 2020, 29 (02) :169-178
[37]   Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer [J].
Mahdian-shakib, Ahmad ;
Dorostkar, Ruhollah ;
Tat, Mahdi ;
Hashemzadeh, Mohammad Sadegh ;
Saidi, Navid .
BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 :592-600
[38]   YAP1 affects the prognosis through the regulation of stemness in endometrial cancer [J].
Kong, Wei ;
Huang, Yuzhen ;
Jiang, Peng ;
Tu, Yuan ;
Li, Ning ;
Wang, Jinyu ;
Zhou, Qian ;
Zheng, Yunfeng ;
Gou, Shikai ;
Tian, Chenfan ;
Yuan, Rui .
PEERJ, 2023, 11
[39]   Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer [J].
Tan, Dan ;
Sheng, Li ;
Yi, Qing-Hua .
CANCER BIOMARKERS, 2018, 21 (02) :287-297
[40]   BECN1 and BRCA1 Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis [J].
Salwa, Amreen ;
Ferraresi, Alessandra ;
Chinthakindi, Menaka ;
Vallino, Letizia ;
Vidoni, Chiara ;
Dhanasekaran, Danny N. ;
Isidoro, Ciro .
BIOMEDICINES, 2021, 9 (02) :1-17